WASHINGTON, D.C. (September 27, 2011) – With attendees from across the United States and the European Union including Germany, France and Ireland, as well as from India, China, Japan, Israel, Australia, New Zealand, Canada, Brazil and Mexico, AdvaMed 2011 features global life changing medical innovations on the exhibit hall floor and during the company presentation forum. Panels today focus on the intersection of healthcare and IT, updates on personalized medicine, the impact of tax reform, the future of the IVD directive, the “Pulse of the Industry,” bringing products to market, and differences between the E.U. and U.S. regulatory structures.
“With five CEOs Unplugged sessions, 21 educational panels, the opening of Innovation Alley in the exhibit hall, and a plenary address by President George W. Bush, AdvaMed 2011 will be the place to be today,” said Caroll Neubauer, CEO of B. Braun of America and AdvaMed 2011 Conference Chairman.
James V. Mazzo, president of Abbott Medical Optics and Chairman of the Board for AdvaMed will introduce the 43rd President of the United States. “Too little credit is given to his Administration’s significant accomplishments in the areas of health care innovation and access,” said Mazzo. “During his Administration, for the first time pharmaceutical benefits were provided to seniors as part of the Part D benefit created by the Medicare Modernization Act (MMA) and his Emergency Plan for AIDS Relief provided medications and care to millions of AIDS sufferers and their children around the world.” In a one-on-one dialogue during the plenary the President will be asked about his biggest domestic healthcare success, Social Security reform and national security matters.”
AdvaMed 2011 will feature 21 educational panels focusing on business development and finance, emerging company issues, eHealth, InVitro diagnostics, health policies and quality topics. Experts will discuss the latest in structuring successful strategic partnerships, negotiating medical product outsourcing agreements, the impact of the 510(k) review process, accessing the UK healthcare markets, tax reforms, empowering patients with technology, and a host of other business, policy and innovation topics.
“Jobs and innovation go hand-in-hand and today’s second plenary session Indiana Governor Mitchell Daniels will focus on medical device and diagnostics companies and their success in the Hoosier state,” said Neubauer. “We’ll also be hearing from Mikel Arriola, the COFEPRIS Commissioner regarding regulatory policies in Mexico, and from officials from India on the state of the healthcare market in their country. In addition, we are looking forward to bringing together the venture capital, angel and private equity communities with the innovators, entrepreneurs and medical technology leaders in our company presentation forum. It’s going to be an exciting day.”
In the U.S. alone, the medical device and technology industry supports more than 2 million high paying American jobs, and accounts for 40 percent of the global medical technology market.